Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1995 | 1 |
2016 | 1 |
2017 | 2 |
2018 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Once-Weekly Basal Insulin Fc Demonstrated Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With Type 2 Diabetes: A Phase 2 Randomized Control Trial.
Diabetes Care. 2023 May 1;46(5):1060-1067. doi: 10.2337/dc22-2396.
Diabetes Care. 2023.
PMID: 36944059
Free PMC article.
Clinical Trial.
Novel Once-Weekly Basal Insulin Fc Achieved Similar Glycemic Control With a Safety Profile Comparable to Insulin Degludec in Patients With Type 1 Diabetes.
Kazda CM, Bue-Valleskey JM, Chien J, Zhang Q, Chigutsa E, Landschulz W, Wullenweber P, Haupt A, Dahl D.
Kazda CM, et al. Among authors: bue valleskey jm.
Diabetes Care. 2023 May 1;46(5):1052-1059. doi: 10.2337/dc22-2395.
Diabetes Care. 2023.
PMID: 36920867
Free PMC article.
Clinical Trial.
Item in Clipboard
Cytokeratin-18 and enhanced liver fibrosis scores in type 1 and type 2 diabetes and effects of two different insulins.
Sanyal A, Cusi K, Hartman ML, Zhang S, Bastyr EJ 3rd, Bue-Valleskey JM, Chang AM, Haupt A, Jacober SJ, Konrad RJ, Zhang Q, Hoogwerf BJ.
Sanyal A, et al. Among authors: bue valleskey jm.
J Investig Med. 2018 Mar;66(3):661-668. doi: 10.1136/jim-2017-000609. Epub 2017 Nov 21.
J Investig Med. 2018.
PMID: 29167192
Clinical Trial.
Item in Clipboard
The role of neuropeptide Y in the antiobesity action of the obese gene product.
Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, et al.
Stephens TW, et al. Among authors: bue valleskey jm.
Nature. 1995 Oct 12;377(6549):530-2. doi: 10.1038/377530a0.
Nature. 1995.
PMID: 7566151
Item in Clipboard
Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes.
Cusi K, Sanyal AJ, Zhang S, Hartman ML, Bue-Valleskey JM, Hoogwerf BJ, Haupt A.
Cusi K, et al. Among authors: bue valleskey jm.
Diabetes Obes Metab. 2017 Nov;19(11):1630-1634. doi: 10.1111/dom.12973. Epub 2017 Jun 22.
Diabetes Obes Metab. 2017.
PMID: 28417532
Item in Clipboard
Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes.
Cusi K, Sanyal AJ, Zhang S, Hoogwerf BJ, Chang AM, Jacober SJ, Bue-Valleskey JM, Higdon AN, Bastyr EJ 3rd, Haupt A, Hartman ML.
Cusi K, et al. Among authors: bue valleskey jm.
Diabetes Obes Metab. 2016 Oct;18 Suppl 2:50-58. doi: 10.1111/dom.12751.
Diabetes Obes Metab. 2016.
PMID: 27723227
Item in Clipboard
Cite
Cite